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Efficient translation of mouse hypoxia-inducible factor-1alpha
under normoxic and hypoxic conditions
Abstract
The heterodimeric hypoxia-inducible factor-1 (HIF-1), consisting of the subunits HIF-1alpha and
HIF-1beta/ARNT, is a master transcriptional regulator of oxygen homeostasis. Under hypoxic
conditions, HIF-1alpha levels very rapidly increase, mostly due to protein stabilization. However,
translational regulation of HIF-1alpha has not been directly analyzed so far. Mouse HIF-1alpha exists as
two mRNA isoforms (termed mHIF-1alphaI.1 and mHIF-1alphaI. 2) containing structurally different
5'-termini which might modulate translation initiation. Whereas the in vitro translation efficiency of
these two mRNA isoforms was about equal, the mHIF-1alphaI.2 5'-untranslated region (5'-UTR)
conferred significantly higher in vivo luciferase reporter gene activity than the mHIF-1alphaI.1 5'-UTR.
Similar corresponding luciferase mRNA levels indicate translational rather than transcriptional
alterations. Reporter gene expression was not affected upon exposure of transiently transfected cells to
hypoxia (1% oxygen). Direct assessment of translational regulation by polysomal profile analysis of
HeLaS3 cells showed that HIF-1alpha (and to a lower extent ARNT) mRNA was found mainly in the
translationally active polyribosomal fractions under both normoxic and hypoxic conditions. In contrast,
the association of mRNAs for beta-actin and ribosomal protein L28 with the polyribosomal fractions
was substantially reduced under hypoxic conditions, suggesting decreased overall protein synthesis.
Thus, efficient translation of mouse HIF-1alpha in a situation where the general translation efficiency is
reduced represents a prerequisite for the very rapid accumulation of HIF-1alpha protein upon exposure
to hypoxia.
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 Abstract 
 The heterodimeric hypoxia-inducible factor-1 (HIF-1), consisting of the 
subunits HIF-1α and HIF-1β/ARNT, is a master transcriptional regulator of oxygen 
homeostasis. Under hypoxic conditions, HIF-1α levels very rapidly increase, mostly 
due to protein stabilization. However, translational regulation of HIF-1α has not been 
directly analyzed so far. Mouse HIF-1α exists as two mRNA isoforms (termed mHIF-
1αI.1 and mHIF-1αI.2) containing structurally different 5’ termini which might 
modulate translation initiation. Whereas the in vitro translation efficiency of these two 
mRNA isoforms was about equal, the mHIF-1αI.2 5’ untranslated region (UTR) 
conferred significantly higher in vivo luciferase reporter gene activity than the mHIF-
1αI.1 5’UTR. Similar corresponding luciferase mRNA levels indicate translational 
rather than transcriptional alterations. Reporter gene expression was not affected 
upon exposure of transiently transfected cells to hypoxia (1% oxygen). Direct 
assessment of translational regulation by polysomal profile analysis of HeLaS3 cells 
showed that HIF-1α (and to a lower extent ARNT) mRNA was found mainly in the 
translationally active polyribosomal fractions under both normoxic and hypoxic 
conditions. In contrast, the association of mRNAs for β-actin and ribosomal protein 
L28 with the polyribosomal fractions was substantially reduced under hypoxic 
conditions, suggesting decreased overall protein synthesis. Thus, efficient 
translation of mouse HIF-1α in a situation where the general translation efficiency is 
reduced represents a prerequisite for the very rapid accumulation of HIF-1α protein 
upon exposure to hypoxia. 
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 1. Introduction 
 An adequate supply of oxygen is mandatory for regulated function of cells and 
organs. Adaptation to situations of limited oxygen supply is ensured by modulating 
the expression of oxygen-responsive genes. Although significant progress has been 
made in understanding the molecular response to hypoxia, the precise mechanisms 
of oxygen sensing, transduction of the hypoxic signal, and transcriptional regulation 
of hypoxic gene expression remain to be elucidated. The hypoxia-inducible factor-1 
(HIF-1), initially identified as the transcription factor responsible for upregulation of 
erythropoietin mRNA expression under hypoxic conditions [1], has now been 
recognized to play a key role in the widely distributed transcriptional mechanisms 
activated by reduced oxygen supply [2-4]. Apart from erythropoietin, functionally 
critical HIF-1 DNA binding sites have been identified in many hypoxia-responsive 
genes including vascular endothelial growth factor (VEGF), several glycolytic 
enzymes, glucose transporter-1, inducible nitric oxide synthase, heme oxygenase-1 
and transferrin [3].  
 The heterodimeric transcription factor HIF-1 consists of the subunits HIF-1α 
and HIF-1β which both belong to a subfamiliy of the basic-helix-loop-helix class of 
transcription factors harboring a region of homology termed PAS. HIF-1β was found 
to be identical to the aryl hydrocarbon receptor nuclear translocator (ARNT) that was 
originally cloned as a heterodimerization partner of the aryl hydrocarbon receptor, 
better known as the dioxin receptor [5]. On the other hand, HIF-1α, the rate limiting 
factor in HIF-1 activation, represents a novel protein of the basic-helix-loop-helix-
PAS subfamily. In contrast to ARNT, HIF-1α protein is hardly detectable under 
normoxic conditions. Exposure to hypoxia very rapidly induces HIF-1α protein 
expression. Although originally believed to be regulated also at the mRNA level, it is 
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 now commonly accepted that HIF-1α mRNA is expressed constitutively in in vitro 
cultured cell lines [6]. However, in certain chronically hypoxic situations in vivo, HIF-
1α mRNA inductions have been reported [7], but it is not known whether 
transcriptional or post-transcriptional mechanisms are responsible for these effects. 
 In principle, the intracellular protein content can be regulated by translational 
control and/or via protein stability. Whereas HIF-1α protein is unstable in normoxia, 
hypoxia stabilizes HIF-1α and markedly prolongs its half-life [8]. The rapid 
degradation under normoxic conditions is mediated by the ubiquitin-proteasome 
system in a von-Hippel-Lindau tumor suppressor protein-dependent manner [9-12]. 
Indeed, two domains that confer HIF-1α stability under hypoxia have been identified 
[10, 13-17]. 
 Although modulation of protein stability appears to be a critical step in the 
regulation of HIF-1α under different oxygen concentrations, it is not known how 
translational control mechanisms contribute to the regulation of HIF-1α expression. 
Such regulatory mechanisms might be related to our recent finding that the mouse 
HIF-1α gene (Hif1a) contains two alternative first exons (designated exon I.1 and I.2) 
which are expressed from two alternative promoters [18-20]. Thus, mouse HIF-1α 
(mHIF-1α) mRNA exists as two distinct isoforms: the tissue-specific isoform (mHIF-
1αI.1) that so far has only been detected in mice, and the housekeeping-type 
isoform (mHIF-1αI.2) that is ubiquitously expressed and represents the mouse 
homologue of the so far sole human HIF-1α isoform [1, 21]. These two mRNA 
isoforms contain distinct 5’UTRs which can be distinguished by their G+C content as 
well as by the translation initiation codons, suggesting that they might be 
differentially translated. In the present work, we investigated the role of both 5’UTRs 
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 and the common 3’UTR in translational regulation of the two mHIF-1α isoforms 
under normoxic and hypoxic conditions. 
 
2. Materials and methods 
2.1. Plasmid constructs 
 For in vitro transcription/translation studies of mHIF-1α, T7 RNA polymerase 
promoter-containing plasmids were constructed as follows (Fig. 1A): pmHIFI.1 was 
obtained by inserting a 134 bp SspI-BstXI fragment derived from the λ phage clone 
λH13 [19], which contains exon I.1 genomic Hif1a sequences, into the plasmid 
pmfcH that harbors the full length mHIF-1αI.1 cDNA [18]. This construct (termed 
pmHIFI.1) contains an almost complete exon I.1-derived 5’UTR but misses 21 bp 
(bp 41-21) upstream of the translation initiation site. The exon I.2 sequence of mHIF-
1α was obtained from a 369 bp BamHI-BglII cDNA fragment (kindly provided by A. 
Damert, Bad Nauheim, Germany) that was cloned into the BamHI-BglII site of 
plasmid pmfcH giving rise to pmHIFI.2.2. This plasmid contained 252 bp of the exon 
I.2 5’UTR. To generate plasmid pmHIFI.2.1 harboring full length 5’UTR of exon I.2, a 
286 bp SnoI-NcoI fragment derived from phage clone λH30 [20] was inserted into 
the NotI-NcoI site of pmHIFI.2.2. Note that all plasmids mentioned above contained 
full mHIF-1α coding sequence and 894 bp 3’UTR sequence. To test the translational 
capacity of the 5’UTR (I.1 and I.2) and the 3’UTR of HIF-1α, the corresponding 
UTRs of the luciferase-containing reporter gene pGL3Promoter (Promega) were 
replaced as follows (Fig. 1B): pGLmHIFI.1 was constructed by inserting a 147 bp 
SspI-HincII exon I.1 fragment into the HindIII-NcoI site of pGL3Promoter vector 
downstream of the simian virus 40 (SV40) promoter and upstream of the luciferase 
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 coding region. The inserted fragment was derived from the clone λH13 [19] and 
contained the transcriptional start site and 113 bp of the 5’UTR. Similarly, a 344 bp 
HindIII-NcoI fragment containing 251 bp of exon I.2. 5’UTR sequence (kindly 
provided by A. Damert) was inserted into the HindIII-NcoI site of vector 
pGL3Promoter followed by removal of an 85 bp excess polylinker sequence by 
digestion with EcoRI and religation yielding plasmid pGLmHIFI.2.2. Plasmid 
pGLmHIFI.2.1 containing the full-length exon I.2 5’UTR sequence was obtained by 
inserting a 286 bp SnoI-NcoI fragment from clone λH30 (see above), into the HindIII-
NcoI site of the pGL3Promoter vector. Full length 3’UTR was obtained from mHIF-1α 
cDNA [18] after digestion with HpaI (cuts three bp upstream of the stop codon) and 
XhoI (cuts in the polylinker). The resulting 1270 bp fragment was used to replace the 
luciferase 3’UTR (BamHI-XbaI) of vector pGL3Promoter, yielding pGLmHIF3’UTR 
(Fig. 1B). Similarly, the constructs pGLmHIFI.1.3’UTR and pGLmHIFI.2.3’UTR were 
obtained by inserting the HpaI-XhoI 3’UTR fragments described above into BamHI-
XbaI sites of pGLmHIFI.2.2 and pGLmHIFI.1, respectively. The hypoxia-responsive 
luciferase reporter gene construct pGLEpoHBS.3, containing three copies of the 
erythropoietin 3’ enhancer-derived HIF-1-binding site (HBS, 18 bp) has been 
described previously [22]. 
 
2.2 In vitro translation and Western blot analysis 
 The following plasmids were used for in vitro translation: pmHIFI.1, 
pmHIFI.2.1 and pmHIFI.2.2 (see above); pBSKhHIF1αT7 (hHIF-1α, kind gift of G. L. 
Semenza, Baltimore, MD); pBSK-HLF and pBShARNTKS+ (mHIF-2α and hARNT, 
respectively, kind gift of Y. Fujii-Kuriyama, Tohoku, Japan). In vitro translation was 
performed using a coupled transcription/translation system according to the 
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 manufacturer’s instructions (Promega). Translation products were subjected to 
Western blot analysis as described previously [23]. Briefly, equal aliquots (5 μl) of 
these reactions were separated by 7.5% SDS-polyacrylamide gel electrophoresis 
(PAGE) and transferred to nitrocellulose membranes (Schleicher & Schuell). HIF-1 
was detected using polyclonal IgY antibodies or the monoclonal antibody mgc3 [23]. 
Alkaline phosphatase-coupled secondary antibodies derived against chicken IgY 
and mouse IgG were purchased from Promega and Sigma, respectively. 
Colorimetric detection was performed with bromochloroindoyl phosphate and nitro 
blue tetrazolium according to standard protocols.  
 
2.3 Electrophoretic mobility shift assay 
 Electrophoretic mobility shift assays were performed as described previously 
[24]. Briefly, 5 µl each of in vitro synthesized hHIF-1α and mHIF-1α protein (see 
above) were allowed to interact with 5 µl of in vitro translated human ARNT at room 
temperature for 30 min before addition of binding buffer and carrier DNA. An 
annealed, 5’ end-labeled oligonucleotide (5’-GCCCTACGTGCTGTCTCA-3’) derived 
from the human erythropoietin 3’ enhancer was used as probe [22]. Where 
indicated, this mixture was preincubated with the monoclonal antibody mgc3 [23] for 
30 min on ice before incubation at 4°C over night.  
 
2.4 Cell culture and transfection 
 The human hepatoma cell line HepG2 (American Type Culture Collection, 
ATCC HB8065) and the human epitheloid carcinoma cell line HeLaS3 (ATCC CCL-
2.2) were purchased from ATCC. The mouse hepatoma cell line Hepa1, also termed 
Hepa1c1c7 [25], was a kind gift of L. Poellinger (Stockholm, Sweden) and the 
7 
 human neuroblastoma cell line SK-N-MC (ATCC HTB-10) was kindly provided by U. 
Dürer (Jena, Germany). HeLaS3 cells were cultivated in suspension in Ham's F12 
medium (Life Technologies) containing 10% heat-inactivated fetal calf serum 
(Boehringer-Mannheim), 100 U/ml penicillin, 100 µg/ml streptomycin, 1 x minimal 
essential medium non-essential amino acids, 2 mM L-glutamine and 1 mM sodium 
pyruvate (all from Life Technologies). The other cell lines were grown in Dulbecco's 
modified Eagle's medium (DMEM, high glucose, Life Technologies) supplemented 
as above. All cell lines were kept at 37°C in a humidified atmosphere containing 5% 
CO2. Oxygen tensions in the incubator (Forma Scientific, model 3319) were either 
140 mm Hg (20% O2 vol/vol, normoxia) or 7 mm Hg (1% O2 vol/vol, hypoxia). 
 For transient transfections, 1 x 107 cells were washed with PBS, resuspended 
in 350 µl medium without fetal calf serum and co-transfected with 45 µg luciferase 
reporter gene construct and 5 µg of the pRL-SV40 renilla luciferase control vector 
(Promega) by electroporation at 250 V and 960 µF (Gene-Pulser, Bio-Rad). Cells 
were split into two aliquots, plated onto 6-well plates and incubated for various time 
points at either 20% O2 or 1% O2 as described above. Cells were washed twice with 
PBS on ice and lysed in reporter lysis buffer (Promega). Firefly luciferase and renilla 
luciferase activities were measured in a Lumat LB9501 luminometer (Berthold) using 
the reagents provided with the dual luciferase kit according to the manufacturer's 
recommendations (Promega). Differences in transfection efficiency and extract 
preparation were corrected by normalization to the corresponding renilla luciferase 
activities. 
 
2.5 Northern blot analysis 
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  Total cellular RNA from transfected HeLaS3 cells was prepared according to 
standard protocols [26]. Total RNA (15 µg) was separated by electrophoresis 
through a 1% agarose gel containing 6% formaldehyde dissolved in 0.04 mM 
morpholinopropanesulfonic acid, 0.01 M sodium acetate, 1 mM EDTA, pH 7.0 and 
transferred to a Biodyne A nylon membrane (Pall). Luciferase (Promega) and β-actin 
[18] cDNA probes were labeled with 32P-dCTP by random priming, and hybridization 
was performed at 42°C for 16 h as described previously [27]. The blots were washed 
to a final stringency of 0.1 x SSC, 0.2% SDS at 50°C for two hours. Exposure to a 
phosphorimager screen allowed mRNA quantitation by a Molecular Dynamics 
PhosphorImager using ImageQuant software. The images were displayed using a 
linear relationship between signal and image intensity. 
 
2.6 Polysomal profile 
 HeLaS3 cells (4 x 108) were diluted in 8 ml complete medium and incubated 
in tonometers at either 20% O2 or 0.5% O2 for 1 h as described previously [28]. Cells 
were collected on ice and washed twice with PBS containing 10 µg/ml cycloheximide 
(Sigma) to block translation. The pellets were snap frozen in liquid nitrogen and 
stored at -80°C until use. For preparation of cytoplasmic fractions, the pellets were 
resuspended in 4 volumes of buffer A (10 mM Tris-HCl pH 7.8, 1.5 mM MgCl2, 10 
mM KCl) containing 2 µg/ml aprotinin, 2 µg/ml pepstatin, 2 µg/ml leupeptin (all from 
Boehringer-Mannheim), 1 mM Na-vanadate, 0.5 mM DTT, 0.4 mM 
phenylmethylsulfonyl fluoride (all from Sigma), 20 U/ml RNasin (Promega), and 150 
µg/ml cycloheximide. The cells were swollen on ice for 10 min, dounce homogenized 
with 10 strokes of a type B pestle and centrifuged at 800 x g for 10 min at 4°C. The 
supernatant was further centrifuged at 150,000 x g for 5 min and the protein content 
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 was determined in the supernatant using the Bradford assay (Bio-Rad). Five mg of 
protein was layered on top of a 15-40% sucrose gradient in buffer A and centrifuged 
at 35,000 rpm for 1h 50 min at 4°C in a TST41.14 rotor. The OD260 was measured in 
each 500 µl sample collected from the sucrose gradients. RNA was prepared from 
each fraction by adding 10 µl 10% SDS and 100 µg proteinase K (Boehringer-
Mannheim) and incubating the samples at 56°C for 30 min. After phenol-chloroform 
purification and ethanol precipitation, the pellets were dissolved in DEPC-treated 
H2O. An aliquot of each sample was used for spectrophotometric RNA quantification. 
Volumes were maintained constant throughout the whole procedure, and all of the 
RNA obtained from each fraction was run on formaldehyde gels before Northern 
blotting. The blots were then hybridized with human HIF-1α, ARNT, β-actin, L28 and 
28S cDNA probes. Radioactive signals were recorded and quantified as described 
above. 
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 3. Results 
3.1 Similar in vitro translation efficiencies of the two mHIF-1α mRNA 
isoforms 
 The 5’UTRs of the two mouse HIF-1α mRNA isoforms mHIF-1αI.1 and mHIF-
1αI.2 exhibit considerable differences in their G+C content as well as in the ATG 
translation initiation codon regions [18-20]. The mHIF-1αI.2 5’UTR contains 73% 
G+C compared to 51% in the mHIF-1αI.1 5’UTR. The secondary structures of the 
two 5’UTR sequences were calculated using the m-fold 3.0 programme [29, 30]. The 
predicted free energy for mHIF-1αI.1 was -31 kcal/mol compared to -111 kcal/mol for 
mHIF-1αI.2.1, and formation of a hairpin loop was found at the 5’ end of mHIF-1αI.2 
mRNA. Plasmid templates containing either the mHIF-1αI.1 (pmHIFI.1) or the mHIF-
1αI.2 (pmHIFI.2.1) cDNA were used for in vitro translation in a coupled T7 RNA 
polymerase/rabbit reticulocyte lysate system. To test whether the predicted hairpin 
loop influences translation, the plasmid pmHIFI.2.2 lacking the first 28 bp of mHIFI.2 
(Fig. 1) was also analyzed. Plasmids containing human HIF-1α (phHIF-1α) and 
mouse HIF-2α (pmHIF-2α) cDNAs served as positive and negative controls, 
respectively. 
 Western blot analysis revealed no significant differences in the efficiency of in 
vitro protein synthesis of the plasmids analyzed (Fig. 2). In addition, no differences 
were found in the in vitro transcription efficiencies alone (data not shown). 
Premature translational termination resulted in protein products of lower molecular 
weight than expected, but the translational efficiency could still be determined 
because the products were of equal size. The specificity of the used polyclonal IgY 
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 antibody [23] was demonstrated by the lack of signals when using the pmHIF-2α 
plasmid as template. 
 
3.2 Both mHIF-1α protein isoforms form functional DNA-binding 
complexes 
 The predicted mHIF-1α protein isoforms differ in their amino terminal end, 
mHIF-1αI.1 being 12 amino acids shorter than mHIF-1αI.2. Because the basic-helix-
loop-helix region resides very close to this truncation, the DNA-binding activity of the 
mHIF-1αI.1 protein isoform might be affected. Thus, we tested the various in vitro 
synthesized HIF-1α proteins shown in Fig. 2 for their capability to form functionally 
active DNA-binding complexes with in vitro synthesized ARNT. Electrophoretic 
mobility shift assays were performed using an oligonucleotide containing the HIF-1 
binding site (HBS) derived from the erythropoietin 3’ enhancer. As shown in Fig. 3, 
both mHIF-1α isoforms were able to form a heterodimeric DNA-binding complex of 
comparable size with human ARNT. As shown previously [31], C-terminal truncation 
of the in vitro translation products (see above) does not affect heterodimerization 
and DNA binding of HIF-1. The specificity of the HIF-1 DNA binding complexes was 
confirmed by the disappearance of the bands following addition of the anti-hHIF-1α 
monoclonal antibody mgc3 [23] to the DNA-binding reactions. In the absence of 
ARNT, none of the in vitro synthesized HIF-1α proteins were able to bind the HBS 
oligonucleotide (data not shown). Thus, the lack of the first 12 amino acids adjacent 
to the DNA-binding basic-helix-loop-helix region of mHIF-1α does not abolish the 
DNA-binding activity. 
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 3.3 The mHIF-1α exon I.2 but not exon I.1 5’UTR efficiently enhances 
reporter gene translation in normoxic cells 
 We next tested the impact of the mHIF-1α UTRs on the in vivo translation 
efficiencies. Therefore, the 5’ and/or 3’ UTRs of a heterologous, SV40 promoter-
driven firefly luciferase reporter gene were replaced by the corresponding regions of 
the mHIF-1α isoforms (see Fig. 1B). Human neuroblastoma (SK-N-MC), mouse 
hepatoma (Hepa1) and human HeLaS3 cells were transiently transfected and 
incubated for 16 hours under normoxic conditions. To normalize for differences in 
transfection efficiency, a Renilla luciferase expression vector was co-transfected and 
the results were expressed as relative values compared to the activity of the parental 
plasmid pGL3Promoter (Fig. 4). 
 Whereas the exon I.1-derived 5’UTR did not significantly enhance reporter 
gene expression in all three cell lines tested, the exon I.2-derived 5’UTR was 5.4 to 
9.5 fold more active than the parental luciferase 5’UTR, irrespective of the presence 
of the predicted hairpin loop. The mHIF-1α-derived 3’UTR alone or in combination 
with the exon I.1-derived 5’UTR did not significantly increase luciferase activity. 
However, the 3’UTR reduced mHIF-1αI.2 5’UTR-directed luciferase activity by 40-
60% in all three cell lines tested. This observation suggests that sequences within 
the 3’UTR interact with sequences in the exon I.2 (but not exon I.1) 5’UTR, thereby 
negatively modulating luciferase expression. 
 To distinguish between transcriptional and translational effects of the different 
UTRs on luciferase expression, luciferase mRNA steady state levels and luciferase 
activities were determined in transiently transfected HeLaS3 cells (Fig. 5). When 
compared to the parental vector pGL3Promoter, luciferase mRNA levels (normalized 
to β-actin mRNA levels) were not markedly altered after transfection with constructs 
13 
 containing the mHIF-1α 5’UTRs. However, the ratios between luciferase activity and 
mRNA level were significantly higher in the constructs containing mHIF-1α 5’UTRs 
compared to the parental vector (Fig. 5), with pGLmHIFI.2.1 and pGLmHIFI.2.2 
showing significant higher ratios than pGLmHIFI.1. Thus, the mHIFI.2 and to a lower 
extent mHIFI.1 5’UTRs upregulated translation rather than transcription of the 
luciferase gene. As above, translational efficiency was reduced when the mHIF-1α 
3’UTR was included in the constructs used for transfection.  
 
3.4 Hypoxia does not affect mHIF-1α UTR-dependent translational 
regulation 
 To investigate if hypoxia modulates reporter gene translation enhanced by the 
HIF-1α UTRs, the plasmids described above were transiently transfected into 
HeLaS3, Hepa1, SK-N-MC and HepG2 cells which were subsequently split and 
exposed to 20% or 1% oxygen for 8 to 24 hours. When compared to normoxia, 
hypoxic incubation did not significantly alter luciferase activity of these constructs in 
all three cell lines (Table 1). 
 
3.5 Hypoxia impairs general but not HIF-1α translation 
 To elucidate whether hypoxia affects translational efficiency of endogenous 
HIF-1α, we investigated the association of HIF-1α mRNA with ribosomal and non-
ribosomal fractions (translationally active and inactive mRNA, respectively). 
Translational activation is manifested as a shift from non-polyribosomal into 
polyribosomal fractions or from smaller to larger polyribosomal fractions. HeLaS3 
cells were exposed for 1 hour to 20% or 0.5% oxygen which has been shown 
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 previously to optimally induce HIF-1α protein [28]. In each experiment, hypoxic 
induction was verified by electrophoretic mobility shift assays of HIF-1 DNA binding 
activity (data not shown). Cytoplasmic extracts were centrifuged on a sucrose 
gradient and a total of 20 fractions were collected. The distribution of rRNA in 
polysomes, monosomes and free ribonucleoproteins was determined by 
spectrophotometry (Fig. 6, upper part). Whereas under normoxic conditions rRNA 
was associated with polysomes, a considerably higher rRNA association with 
monosomes was observed under hypoxic conditions. This suggests that general 
translation is reduced in hypoxic cells.  
 Under normoxic conditions, most of HIF-1α mRNA was associated with large 
and small polyribosomes as determined by Northern blotting of each fraction (Fig. 6, 
lower part). In contrast, L28 control mRNA was mainly bound to smaller 
polyribosomes, suggesting that HIF-1α is very efficiently translated in normoxic cells. 
Upon exposure to hypoxia, mHIF-1α mRNA distribution was not significantly altered 
whereas L28 mRNA was consistently shifted towards monosomes. For a statistical 
analysis, the fractions containing large (Pl) and small (Ps) polyribosomes, 
monosomes (m) and free RNA (f) were pooled and HIF-1α, ARNT, L28 and β-actin 
mRNA was determined by Northern blotting. As shown in Fig. 7, a high proportion of 
HIF-1α mRNA was associated with polyribosomes under both normoxic and hypoxic 
conditions. While ARNT mRNA was equally distributed among all fractions under 
normoxic conditions, a slight shift from free RNA to monosomes was observed 
following hypoxic exposure. In contrast, the ribosomal protein L28 and β-actin 
mRNAs showed a significant hypoxic redistribution from polyribosomes to 
monosomes.  
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 4. Discussion 
 Mouse HIF-1α is expressed as two mRNA isoforms, mHIF-1αI.1 and mHIF-
1αI.2, which differ by their 5’UTRs and translational start sites [19, 20]. Here, we 
showed that the in vitro transcription/translation and DNA-binding efficiencies of the 
two isoforms are about equal, despite different G+C contents and the lack of the first 
twelve amino acids adjacent to the basic-helix-loop-helix DNA-binding region in the 
I.1 isoform. 
 In vivo, the Hif1a exon I.2-derived 5’UTR, but not the exon I.1-derived 5’UTR, 
conferred very efficient translation of a reporter gene. Likewise, the transcription 
factor Pax6 also contains two different 5'UTRs and chimeric reporter gene activity 
has been found to be significantly higher if driven by the ubiquitously expressed 
5'UTR compared to the tissue-specific 5'UTR [32]. Efficient translation from the 
mHIF-1αI.2 5’UTR was rather unexpected since a high G+C content usually inhibits 
rather than activates translation [33]. Moreover, this efficient translation was not 
affected by exposure of the cells to hypoxic conditions. Similar findings were 
reported for the oxygen-regulated genes VEGF [34], platelet-derived growth factor 
and fibroblast growth factor [35]. In these cases, translation was cap-independent 
due to the presence of internal ribosome entry sites (IRESs). Optional use of internal 
initiation of translation might be advantageous in stress situations such as hypoxia 
where cap-dependent translation is compromised due to rate limitation of certain 
components of the eIF4 complex. Because the HIF-1α 5'UTR is relatively short, it 
remains to be elucidated as to whether it also contains an IRES. Although so far no 
common consensus sequences have been demonstrated for IRES, a putative 
common structural RNA motif forming a stable Y-type folding pattern [36] is 
conserved in several IRESs and is also present in the VEGF gene. A computer-
16 
 assisted sequence analysis of the mHIF-1αI.2 5’UTR predicted a stable Y-formed 
structure. Further experiments are required to determine whether this predicted 
structure can influence mHIF-1αI.2 translation. 
 In contrast to the 5’UTRs, the mHIF-1α 3’UTR negatively regulated in vivo 
translation. Similar translation-inhibiting 3’UTRs have been found in e.g. α2c-
adrenergic receptor [37] and ferritin [38]. Sequence analysis according to Zuker [29] 
revealed that the mHIF-1α 3'UTR was A+U rich (69%) and had a high predicted 
secondary structure of -155 kcal/mol. Furthermore, the 3'UTR contains several 
conserved AUUUA motifs which have been associated with decreased mRNA 
stability [1, 18]. However, further studies will be needed to examine the precise role 
of the 3'UTR in regulating translation of mHIF-1α. 
 Several reports have demonstrated that normoxia results in a decrease in 
HIF-1α protein stability, and that HIF-1α is rapidly degraded via the ubiquitin-
proteasome system mediated by an oxygen-dependent degradation domain (see 
Introduction). Upon hypoxic stimulation, HIF-1α is very rapidly (within few minutes) 
stabilized and escapes proteolytic degradation. However, efficient hypoxic 
translation of HIF-1α, under conditions where general protein synthesis is reduced 
[39, 40], would be a prerequisite for this mechanism. Indeed, we demonstrated by 
polysomal profile analysis that HIF-1α mRNA is associated with translationally active 
polyribosomes, and that - in contrast to other mRNA species - this association is not 
affected by exposure to hypoxia. In addition, ARNT seems to be efficiently translated 
under hypoxic conditions as well. Taken together, our data support the model where 
efficient translation of HIF-1α under both normoxic and hypoxic conditions allows the 
rapid activation of HIF-1α by protection from proteolytic degradation. 
17 
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 Legends to tables and figures 
 
Table 1 Hypoxic modulation of chimeric reporter gene activity 
Cells were transiently transfected with the firefly luciferase reporter gene construct 
depicted in Fig. 1 and incubated for the indicated time periods in parallel under 
normoxic and hypoxic conditions. Relative reporter gene activity was determined 
following normalization to renilla luciferase activity and the ratio between hypoxic 
and normoxic luciferase activity is shown for each construct used. nd: not 
determined. (Mean±SD; n=3-7). 
 
Fig. 1. Plasmid maps. (A) Plasmids used for in vitro transcription/translation of the 
two mHIF-1α isoforms. Plasmid pmHIFI.2.1 contains the full-length mHIF-1αI.2 
5’UTR whereas in pmHIFI.2.2 the first 28 bp of the 5’UTR were deleted. (B) 
Chimeric reporter gene constructs containing mHIF-1αI.1 and mHIF-1αI.2 5’UTR 
and/or 3’UTR sequences linked to the firefly luciferase coding region. All constructs 
were driven by the SV40 promoter. Plasmid pGLEpoHBS3 contains three copies of 
the HIF-1 binding site sequence found in the erythropoietin 3’ enhancer.  
 
Fig. 2. In vitro protein synthesis of mHIF-1αI.1 and mHIF-1αI.2. In vitro 
transcription/translation products of the indicated plasmids (see Fig. 1) were 
analyzed by Western blotting using an affinity-purified polyclonal IgY antibody 
derived against hHIF-1α [23]. 
 
25 
 Fig. 3. Electrophoretic mobility shift assay of in vitro synthesized mHIF-1α isoforms. 
The in vitro protein synthesis products shown in Fig. 2 were mixed with an equal 
volume of in vitro synthesized ARNT, incubated with an oligonucleotide probe 
derived from the erythropoietin 3’ enhancer and analyzed by electrophoretic mobility 
shifts. Addition of the monoclonal antibody mgc3 raised against hHIF-1α 
supershifted the DNA-binding complexes. 
 
Fig. 4. Chimeric mHIF-1α 5’UTR and/or 3’UTR reporter gene assays. The reporter 
genes depicted in Fig. 1B were transiently co-transfected together with a renilla 
luciferase expression vector into SK-N-MC, Hepa1 and HeLaS3 cells. Following 
incubation for 16 hours under normoxic conditions, firefly luciferase activity was 
measured and normalized to the corresponding Renilla luciferase activity. Results 
are shown relative to the activity of the parental pGL3Promoter construct 
(mean±SEM; *p<0.05 vs. pGLmHIFI.2.1; n=3-7). 
 
Fig. 5. Translational contribution to reporter gene expression in transiently 
transfected HeLaS3 cells. HeLaS3 cells were transiently transfected as described for 
Fig. 4. Luciferase and β-actin mRNA levels were determined by Northern blotting, 
and luciferase mRNA levels were normalized to β-actin mRNA levels. The ratio 
between luciferase activity and mRNA levels are expressed relative to the values 
obtained from the parental pGL3Promoter vector, giving an estimate for the relative 
translation rates (mean±SEM; *p<0.05 vs. pGLmHIFI.2.1; n=3). 
 
Fig. 6. Polysomal profile analysis from normoxic and hypoxic HeLaS3 cells. HeLaS3 
cells were incubated for 1 h in 20% O2 (normoxia) or 0.5% O2 (hypoxia). 
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 Cytoplasmic extracts were fractionated by 15-40% sucrose gradient centrifugation, 
20 fractions were collected and the absorbance at 260 nm was determined. Fraction 
numbering goes from the bottom (1) to the top (20) of the sucrose gradient. The 
fractionation into large and small polyribosomes, monosomes and free RNA is 
indicated (upper part). Following total RNA isolation from each fraction, HIF-1α and 
L28 mRNA levels were estimated by Northern blotting (lower part). A representative 
result out of five independent experiments is shown. 
 
Fig. 7. mRNA distribution among polyribosomal, monosomal and free RNA fractions. 
Polysomal profile analyses were performed as described for Fig. 6. Fractions 
containing mRNA associated with large (Pl) and small (Ps) polyribosomes, 
monosomes (m) and free RNA (f) were pooled and the amount of mRNA in each 
fraction in percent of total was determined. The number of independent experiments 
is indicated below each graph (mean±SD). 
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